CATEGORIES
- HGH & Peptide
- Testosterone Series
- Nandrolone Series
- Boldenon Series
- Trenbolone Series
- DHEA Series
- Oral Steroids Series
- Antiestrogen Series
- Estrogen series
- Epinephrine & Thyroxine
- Nootropic API
- SARMs
- Finished Steroid
- Molecularly targeted cancer API
Latest news
- The dosage of HGH
- The History of HGH
- What is HGH?
- High Growth hormone
- How to use HGH?
- The Copy of Growth Hormone
Contact us
- ADD: HongKong
- TEL: skype: sophia.koffeepharm
- FAX: sophia@koffeepharm.com
- E-mail: sophia@koffeepharm.com
Decapeptide-12
- Product description: supply good quality Decapeptide-12 CAS:137665-91-9
PRODUCT INTRODUCTION
Decapeptide-12 |
Basic Info |
Model NO.: Decapeptide-12 |
CAS No:137665-91-9 |
Customized: Customized |
Suitable for: Elderly, Adult |
Purity: >99% |
Express: EMS, DHL, FedEx, etc(Door-to-Door) |
Molecular Formula: C61h88n18o16 |
Specification: Lyophilized Powder |
HS Code: 3301250000 |
owder: Yes |
Certification: GMP, ISO 9001, USP |
State: Powder |
Delivery: Within 24hours After Your Payment |
Name: Decapeptide-12 |
Molecular Weight: 1269.4 |
Transport Package: According to Every Customer′s Requirements |
Origin: China |
Top Quality Decapeptide-12 for Ease Sensitive Skin Polypeptide
Product Description
Decapeptide-12 reduces the appearance of hyperpigmentation-age spots, sun spots, uneven skin tone and photo damage-without the typical side effects of other brighteners like irritation and redness. Plus, soothing antioxidants like licorice root also ease sensitive skin.
The rapidly growing field of targeted tumor therapy often utilizes an antibody, sometimes tagged with a tumor-ablating material such as radioisotope, directed against a specific molecule. This report describes the discovery of nine novel decapeptides which can be radioactively labeled, bind to, and deliver P to colon cancer cells. The decapeptides vary from one another by one to three amino acids and demonstrate vastly different binding abilities. The most avidly binding decapeptide can permanently deliver very high levels of radioisotope to the adenocarcinoma cancer cell lines at an efficiency 35 to 150 times greater than to a variety of other cell types, including cell lines derived from other types of cancer or from normal tissue. This experimental approach represents a new example of a strategy, termed peptide binding therapy, for the potential treatment of colorectal and other adenocarcinomas.